4.8 Article

Microneedle-mediated delivery of Ziconotide-loaded liposomes fused with exosomes for analgesia

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 356, Issue -, Pages 448-462

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2023.03.007

Keywords

Ziconotide; Analgesic; Microneedle; Exosome; Liposome; Borneol

Ask authors/readers for more resources

This study developed microneedles (MNs) by fusing borneol-modified liposomes (LIPs) with exosomes from mesenchymal stem cells (MSCs) and loading them with Ziconotide (ZIC), aiming to improve the delivery efficiency of ZIC across the blood-brain barrier. The results demonstrated that ZIC-loaded MNs had significant analgesic effects in different pain models.
Ziconotide (ZIC) is an N-type calcium channel antagonist for treating severe chronic pain that is intolerable, or responds poorly to the administration of other drugs, such as intrathecal morphine and systemic analgesics. As it can only work in the brain and cerebrospinal fluid, intrathecal injection is the only administration route for ZIC. In this study, borneol (BOR)-modified liposomes (LIPs) were fused with exosomes from mesenchymal stem cells (MSCs) and loaded with ZIC to prepare microneedles (MNs) to improve the efficiency of ZIC across the blood-brain barrier. To evaluate local analgesic effects of MNs, the sensitivity of behavioral pain to thermal and mechanical stimuli was tested in animal models of peripheral nerve injury, diabetes-induced neuropathy pain, chemotherapy-induced pain, and ultraviolet-B (UV-B) radiation-induced neurogenic inflammatory pain. BOR-modified LIPs loaded with ZIC were spherical or nearly spherical, with a particle size of about 95 nm and a Zeta potential of -7.8 mV. After fusion with MSC exosomes, the particle sizes of LIPs increased to 175 nm, and their Zeta potential increased to -3.8 mV. The nano-MNs constructed based on BOR-modified LIPs had good mechanical properties and could effectively penetrate the skin to release drugs. The results of analgesic experiments showed that ZIC had a significant analgesic effect in different pain models. In conclusion, the BORmodified LIP membrane-fused exosome MNs constructed in this study for delivering ZIC provide a safe and effective administration for chronic pain treatment, as well as great potential for clinical application of ZIC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available